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          Mechanical ventilation (MV) is a life-supporting modality that is used  
 
in  a   significant  proportion  of   patients in  intensive  care  units ,  the term  
 
mechanical   ventilation  refers  to  various  artificial  means used to  support  
 
ventilation  and  oxygenation1, 2 
 
          Mechanical ventilation is commonly delivered in intensive care by 
positive pressure ventilation. Positive pressure ventilation modes are defined 
by inspiratory events. Expiration is treated as an independent entity. The 
primary expiratory parameter, positive end expiratory pressure (PEEP) can 
be applied to any of the ventilator modes. 
 
 
VENTILATOR MODES 3, 4 
          The various modes of ventilation are classified based on the types of 
breaths that are selected. The modes most commonly used in pediatric 
practice are discussed here. 
Volume targeted modes : 
1. Controlled Mechanical Ventilation (CMV): In this mode, the ventilator 
controls all the ventilation while patient has minimal or no respiratory effort. 
This is the mode used at the initiation of mechanical ventilation. 
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2. Assisted Mechanical Ventilation (AMV): All breaths are triggered when 
the patient’s inspiratory effort exceeds the preset sensitivity threshold of 
negative pressure. In all other respects, it is similar to controlled mechanical 
ventilation.  
3. Assist Control Ventilation (ACV): ACV is a combination of AMV and 
CMV. In this mode, the patient initiates the breathing as in AMV. However, 
if the patients fails to initiate the breathing within a prescribed time the 
ventilator triggers the breathing and provides a controlled breath as in CMV, 
thus ensuring a guaranteed minute ventilation. 
4. Intermittent Mandatory Ventilation (IMV): It is essentially a combination 
of spontaneous breathing and CMV. A modified circuit provides a 
continuous gas flow that allows the patient to breathe spontaneously with 
minimal work of breathing, At a predetermined frequency, the ventilator 
provides a positive pressure breath to the patient. 
5. Synchronized Intermittent Mandatory Ventilation (SIMV): SIMV allows 
the patient to trigger a mandatory breath in the assist mode thereby 
synchronizing it with the patient’s respiratory effort. However, if the patient 
does not trigger a breath within an allotted time; the ventilator delivers a 
conventional breath. 
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Fig. 1. Airway pressure tracings of the four commonly used volume targeted 
modes. Thick solid lines represent ventilator breaths; thick dotted lines 
represent spontaneous breaths; and thin dotted lines represent spontaneous 
pattern if there are no ventilator breaths.  
 
Pressure targeted modes : 
1. Pressure Support Ventilation (PSV):In this mode, the patient triggers the 
breath as in assisted ventilation. Once initiated the ventilator delivers air and 
gas mixture at a preset positive pressure in the ventilatory circuit. Patients 
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determine their own inspiratory time and tidal volume. It is mainly used as a 
weaning mode and may be  tolerated better than SIMV by some patients. 
2. Pressure Control and Pressure Assist Control Ventilation (PCV and 
PACV):  
This is a time-initiated, pressure-limited and time-cycled mode intended for  
patients requiring total mechanical ventilatory support. Most ventilators also 
allow patient triggering of these breaths; producing pressure assisted breaths. 
Continuous Positive Airway Pressure : 
CPAP is best described as PEEP during spontaneous respiration. It is started 
at 5 cm water and increased by increments of 3 cm water while monitoring 
blood gases. If PaO2 remains <50 mm Hg despite CPAP of 10-12 cm water 
with FiO2 of 1 assisted ventilation is warranted. 
INDICATIONS 5, 6, 7 
Common indications for mechanical ventilation include the following: 
1. Bradypnea or apnea with respiratory arrest 
2. Acute lung injury and the acute respiratory distress syndrome 
3. Tachypnea ( respiratory rate > that for the age )  
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4. Arterial partial pressure of oxygen (PaO2) with a supplemental fraction 
of inspired oxygen (FIO2) of less than 55 mm Hg 
5. Alveolar-arterial gradient of oxygen tension (A-a DO2) with 100% 
oxygenation of greater than 450 mm Hg 
6. Clinical deterioration 
7. Respiratory muscle fatigue 
8. Obtundation or coma 
9. Hypotension 
10. Acute partial pressure of carbon dioxide (PaCO2) greater than 50 mm 
Hg with an arterial pH less than 7.25 
11. Neuromuscular disease 
COMPLICATIONS5, 8  
Common complications of mechanical ventilation are 
1. Complications that are associated with intubation: 
Nasal trauma, tooth avulsion, oral-pharyngeal laceration, laceration or 
hematoma of the vocal cords, tracheal laceration, perforation, hypoxemia, 
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intubation of the esophagus, Sinusitis, tracheal necrosis or stenosis, 
glottic edema etc., 
2. Ventilator induced complications: 
Barotrauma  
Volutrauma 
Oxygen toxicity  
Ventilator-associated pneumonia  
Intrinsic PEEP, or auto-PEEP  
Cardiovascular effects - decrease preload, stroke volume, and cardiac  
output. 
 
WEANING FROM VENTILATOR 
                Once a patient recovers from the illness leading to the application 
of mechanical ventilation, discontinuation of ventilator support and 
extubation must be attempted. The discontinuation process consists of two 
components: weaning (assessing the need for ventilatory support) and 
extubation (assessing the need for an airway). Investigators have 
increasingly focused on the latter component, where 5–20% of extubations 
may fail and require reintubation. In case of unplanned extubation need for 
reintubation can be as high as 23% to 78%9. 
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               Both unnecessarily delayed extubation and 'premature' extubation 
are associated with adverse outcomes. Delayed extubation is associated with 
increased length of stay, increased risk for ventilator-associated pneumonia, 
and increased mortality in brain-injured patients. Conversely, reintubation 
(extubation failure)10,11 after planned extubation is associated with adverse 
outcomes, including increased hospital mortality, prolonged hospital stay, 
higher costs, and greater need for tracheotomy and transfer to post acute 
care. Although the adverse effects of reintubation could reflect the severity 
of underlying illness or could result from complications during reintubation, 
this has not been demonstrated with multivariate analysis. Rather, delayed 
reinstitution11 of ventilatory support may allow for deterioration and new 
organ failure, ultimately contributing to increased mortality and increased 
costs. 
 
WEANING12:  
              
          It is the process of withdrawing mechanical ventilatory support and 
transferring the work of breathing from the ventilator to the patient. It may 
be done abruptly or gradually. 
          Patients who were ventilated for relatively short time (usually no more 
than 1 or 2 days) tolerate an abrupt termination of ventilatory support. But 
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for most other patients successful weaning requires more gradual withdrawal 
of ventilatory support.  
 
WEANING PROCEDURES12: 
             Commonly used are T – tube weaning, synchronized intermittent 
mandatory ventilation (SIMV), continuous positive airway pressure / 
pressure support (CPAP/PSV) ventilation. 
WEANING SUCCESS12: 
            Defined as effective spontaneous breathing without any mechanical 
assistance for 48 hours or more 
WEANING FAILURE12:   
             Weaning failure is defined as one of the following: 1) reintubation 
and/or resumption of ventilatory support following successful extubation 
with in 48 hrs or  
2) death within 48 h following extubation.  
          Weaning from mechanical ventilators depends on the strength of 
respiratory muscles, the load applied to those muscles, and the respiratory 
drive to breathe. Respiratory failure may occur because of any of these. The 
etiology of unsuccessful weaning is the imbalance between the respiratory 
muscle pump and the respiratory muscle load 13,14. This could happen 
secondary to inadequate resolution of initial problem that rendered the 
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patient on mechanical ventilator, a rise of a new problem, a ventilator-
associated complication, or a combination of these factors.  
         The key elements to optimize weaning 15,16 are: (i) to determine cause 
of ventilator dependency,(ii) rectify correctible problems like pulmonary gas  
exchange, fluid balance, mental status, acid-base status, electrolyte 
disturbance, (iii) to consider psychological factors, and (iv) to optimize 
posture and provide ambulation. It is imperative to correct these elements for 
a  successful weaning.  
          An extubation failure17 may occur secondary to upper airway 
obstruction or respiratory secretions that could not be managed by the 
patient. These factors do not manifest themselves until the removal of the 
translaryngeal tube. Significant trauma to the airway from translaryngeal 
intubation is more common in females and increases with increasing 
duration of intubation17. Another potential reason for extubation failure is 
the loss of positive pressure in the thorax after extubation in pressure support 
ventilation (PSV)- weaned patients. 
          A team approach and an organized problem-orientated plan are 
important to expect successful discontinuation of mechanical ventilation. Ely 
et al18 recently demonstrated that a protocol of weaning is superior to the 
physician's individual decision-making at the bedside. 
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          Those investigators found that removal from mechanical ventilation 
was 2 days earlier in the protocol-directed group18. The use of the protocol to 
manage just four patients (95% confidence interval 3-5) would result in one 
individual being off mechanical ventilation after 48 h who otherwise would 
not have been. 
          Recognising and treating the process that caused the patient to go on 
the ventilator is the first goal in liberating him from MV. Weaning 
procedures are usually started only after the underlying disease process that 
necessitated mechanical ventilation has significantly improved or is 
resolved. The patient should also have an adequate gas exchange (most 
studies define this condition as an arterial oxygen tension/fractional inspired 
oxygen ratio higher than 200), appropriate neurological and muscular status, 
and stable cardiovascular function. 
          Weaning indices are objective criteria that are used to predict the 
readiness of patients to maintain spontaneous ventilation. Some parameters 
based on respiratory mechanics, gas exchange, and breathing pattern have 
been proposed as useful predictors of weaning outcome that could guide 
clinicians in determining the optimal time to discontinue mechanical 
ventilation 19-22. 
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Guidelines for weaning  
 
These guidelines, published in 200123 , were developed by a collective task 
force comprising physicians, nurses, and respiratory therapists. 
1. Search for all causes for the patient being ventilator-dependent and correct 
or reverse them. 
2. Perform a formal assessment about readiness to wean if the patient meets 
the criteria listed below. Some patients may still be considered for weaning 
even if one of the following criteria is not met: 
• The cause of the respiratory failure has been partially or fully reversed. 
• The patient’s Pao2/FIO2 > 200, positive end-expiratory pressure is 
between 0 and 8 cm H2O, his FIO2 is less than 0.5, and pH is 7.25 or 
greater. 
• The patient’s hemodynamic status is stable, with no ischemia and no 
clinically important hypotension. 
• The patient can initiate an inspiratory effort. 
3. Perform a formal assessment of readiness to wean. If the patient can 
tolerate a 30- to 120-minute spontaneous breathing trial, he’s ready. 
Tolerance is based on respiratory pattern (no retractions or obvious signs of 
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distress and respiratory rate less than 30 breaths/minute), adequate gas 
exchange, hemodynamic stability, and subjective comfort level. 
4. Once the patient is discontinued from mechanical ventilation, assess 
airwaypatency and his ability to clear secretions. If the airway isn’t patent, 
or if  he can’t clear secretions, leave the artificial airway in place. 
5. If he failed the spontaneous breathing trial, determine and correct the 
cause. Then evaluate him based on guideline 2. If criteria are met, perform a 
spontaneous breathing trial every 24 hours. 
6. Between breathing trials, use a ventilator mode that provides support that 
is stable, nonfatiguing, and comfortable. Let the patient rest to avoid 
overloading the ventilatory muscles. 
7. Use proper analgesics and sedatives at the lowest possible dose, to avoid  
blunting the respiratory drive. 
8. Employ properly designed weaning protocols performed by a therapist 
team. 
9. If the patient will clearly need prolonged mechanical ventilation, he 
should have a tracheostomy. Early in the course of treatment is better than 
later. 
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10. A patient should be classified as permanently ventilator-dependent only 
after 3 months of failed weaning attempts, unless he clearly has irreversible 
disease or injury, such as amyotrophic lateral sclerosis or spinal cord injury. 
11. If weaning attempts in the ICU have failed, transfer a medically stable 
patient to a specialized facility that has a good safety and success record in 
accomplishing ventilator discontinuation. 
12. When a patient has been on prolonged mechanical ventilation, go slowly 
in weaning and gradually increase the time used for spontaneous breathing 
trials. Respiratory muscles need to be retrained and strengthened for patients 
who’ve been ventilator-dependent for prolonged periods. 
          Once a patient has been considered ready to be weaned, the best 
method to assess whether the patient is able to breathe on his or her own is 
to perform a trial of spontaneous ventilation. Ely et al18 showed that 
immediate extubation after successful trials of spontaneous breathing 
expedites weaning and reduces the duration of mechanical ventilation as 
compared with a more gradual discontinuation of ventilatory support. 
Several studies24-30 have demonstrated that 60-80% of mechanically 
ventilated patients can be successfully extubated after passing a trial of 
spontaneous breathing. 
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          Pressure-support, continuous positive airway pressure and T-piece 
trials are the most common methods used to test the readiness for liberation 
from mechanical ventilation. Few random studies26,31 have studied the best 
technique for performing spontaneous breathing trials before extubation. The 
first study31 that dealt with this issue compared continuous positive airway 
pressure of 5 cmH2O and T-piece in a group of 106 mechanically ventilated 
patients who underwent a 1h trial of spontaneous breathing, and no 
difference in the percentage of patients failing extubation was found. 
Because the endotracheal tube imposes a resistive load on the respiratory 
muscles that is inversely related to its cross-sectional diameter, some 
clinicians advocate use of 5-8 cmH2O pressure support to offset this imposed 
load. With this in mind, the study performed by the Spanish Lung Failure 
Collaborative Group26  compared weaning outcome after trials of 
spontaneous breathing with either T-tube or pressure support of 7 cmH2O, 
but no difference was observed in the percentage of patients who remained 
extubated for 48 h (63% in the group assigned to T-tube and 70% in the 
group assigned to pressure support; P = 0.14). 
          The duration of a spontaneous breathing trial has been set at 2 h in 
most Studies26-29. One prospective, multicenter, randomized trial30  of 526 
patients found that trials of spontaneous breathing for 30 or 120 min were 
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equivalent in identifying patients who could tolerate extubation, and that 
patients had reintubation rates of  approximately 13% at 48 h regardless of 
the duration of their T-tube trial. 
          Precise criteria for terminating a weaning trial do not exist, and 
currently trials are terminated on the basis of the clinical judgement of the 
physician. There are two types of criteria used to determine whether a 
patient passes or fails a spontaneous breathing trial: objective criteria32,33 
(abnormal arterial blood gas measurements) and subjective criteria 
(diaphoresis, evidence of increasing effort, tachycardia, agitation, anxiety). 
Patients have clearly failed a spontaneous breathing trial if they develop 
hypercapnia or hypoxaemia. The evaluation of clinical tolerance to 
spontaneous breathing by using exclusively subjective criteria has important 
drawbacks; on the one hand, strict criteria might increase the occurrence of 
unnecessarily prolonged mechanical ventilation but, on the other hand, 
permissive criteria might increase the occurrence of reintubation.  
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Commonly  recommended  criteria for stopping  spontaneous  breathing  
Inability to maintain gas exchange  
      - SPO2 < 95% with FiO2 of 0.4 
Inability to maintain effective ventilation 
- PCO2 of  > 50 mm/Hg or increase of > 10mm/Hg from previous 
value 
- pH < 7.3  
Increased work of breathing 
      -    Respiratory rate in acceptable range 
< 6 months      20 – 60 / min 
6m to 2 yrs      15 – 45 / min 
2 to 5 yrs         15 – 40 / min 
> 5 yrs             10 – 35 / min 
      -   increased use of accessory muscles of  respiration 
      -   paradoxical breathing                                                   
 
Signs of distress 
- diaphoresis 
- anxiety 
- change in mental status(agitation/somnolence) 
- BP – hyper/ hypo tension 
- Heart rate – Brady/ tachy cardia 
           
          There is little risk in performing a closely observed trial of 
spontaneous breathing in patients in whom any acute respiratory failure has 
resolved and who are awake and cardiovascularly stable, in order to assess 
their ability to sustain spontaneous breathing34,35. When the patient remains 
clinically stable with no signs of poor tolerance until the end of the trial, the 
endotracheal tube should be immediately removed. If the patient develops 
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signs of poor tolerance, weaning is considered to have failed and mechanical 
ventilation is reinstituted34-38 . 
          Weaning attempts that are unsuccessful usually indicate incomplete 
resolution of the illness that precipitated the need for mechanical ventilation, 
or the development of new problems. Failure to wean has been attributed to 
an imbalance between the load faced by the respiratory muscles and their 
neuromuscular competence. If a compensated balance of strength and load 
cannot be restored, attempts at spontaneous breathing will be futile. 
Therefore, once a patient fails a spontaneous breathing trial, the clinician 
must comprehensively evaluate the patient, looking for ways to improve his 
or her physiologic status. 
Factors that can lead to weaning failure due to the imbalance between 
ventilatory needs and respiratory capacity 39-42 
Factors that increase the load 
 
1. Bronchospasm 
 
2. Pleural effusion 
 
3. Hyperinflation (intrinsic positive end-expiratory pressure) 
 
4. Airway edema, secretions 
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5. Pneumothorax 
 
6. Alveolar edema 
 
7. Upper airway obstruction 
 
8. Flail chest 
 
9. Infection 
 
10. Obstructive sleep apnea 
 
11. Obesity 
 
12. Atelectasis 
 
13. Endotracheal tube kinking 
 
14. Ascites 
 
15. Interstitial inflammation and/or oedema 
 
16. Secretions encrustation 
 
17. Abdominal distension 
 
18. Ventilatory circuit resistance 
 
Factors that result in decreased neuromuscular competence 
 
1. Drug overdose 
 
2. Electrolyte derangement 
 
3. Critical illness polyneuropathy 
 
4. Brain-stem lesion 
 
5. Malnutrition 
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6. Neuromuscular blockers 
 
7. Sleep deprivation 
 
8. Myopathy 
 
9. Aminoglycosides 
 
10. Hypothyroidism 
 
11. Hyperinflation 
 
12. Guillain-Barré syndrome 
 
13. Starvation/malnutrition 
 
14. Drugs, corticosteroids 
 
15. Mysthenia gravis 
 
16. Metabolic alkalosis 
 
17. Sepsis 
 
18. Phrenic nerve injury 
 
19. Myotonic dystrophy 
 
20. Spinal cord lesion 
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REVIEW OF LITERATURE 
 
 
 
          Esteban et al24 did a comparison of four methods of weaning patients 
from mechanical ventilation. They carried out a prospective, randomized, 
multicenter study involving 546 patients who had received mechanical 
ventilation for a mean (+/- SD) of 7.5 +/- 6.1 days and who were considered 
by their physicians to be ready for weaning. One hundred thirty patients had 
respiratory distress during a two-hour trial of spontaneous breathing. These 
patients were randomly assigned to undergo one of four weaning techniques: 
intermittent mandatory ventilation, in which the ventilator rate was initially 
set at a mean (+/- SD) of 10.0 +/- 2.2 breaths per minute and then decreased, 
if possible, at least twice a day, usually by 2 to 4 breaths per minute (29 
patients); pressure-support ventilation, in which pressure support was 
initially set at 18.0 +/- 6.1 cm of water and then reduced, if possible, by 2 to 
4 cm of water at least twice a day (37 patients); intermittent trials of 
spontaneous breathing, conducted two or more times a day if possible (33 
patients); or a once-daily trail of spontaneous breathing (31 patients). 
Standardized protocols were followed for each technique. The median 
duration of weaning was 5 days for intermittent mandatory ventilation (first 
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quartile, 3 days; third quartile, 11 days), 4 days for pressure-support 
ventilation (2 and 12 days, respectively), 3 days for intermittent (multiple) 
trials of spontaneous breathing (2 and 6 days, respectively), and 3 days for a 
once-daily trial of spontaneous breathing (1 and 6 days, respectively). After 
adjustment for other covariates, the rate of successful weaning was higher 
with a once-daily trial of spontaneous breathing than with intermittent 
mandatory ventilation (rate ratio, 2.83; 95 percent confidence interval, 1.36 
to 5.89; P < 0.006) or pressure-support ventilation (rate ratio, 2.05; 95 
percent confidence interval, 1.04 to 4.04; P < 0.04). There was no significant 
difference in the rate of success between once-daily trials and multiple trials 
of spontaneous breathing. A once-daily trial of spontaneous breathing led to 
extubation about three times more quickly than intermittent mandatory 
ventilation and about twice as quickly as pressure-support ventilation. 
Multiple daily trials of spontaneous breathing were equally successful 7. 
 
          Brochard et al 25. did a Comparison of three methods of gradual 
withdrawal from ventilatory support during weaning from mechanical 
ventilation Among 456 mechanically ventilated patients who met weaning 
criteria, 109 entered into the  study (35 with T piece, 43 with SIMV, and 31 
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with PSV). The three groups were comparable in terms of etiology of disease 
or characteristics at entry in the study. When all causes for weaning failure 
were considered, a lower number of failures was found with PSV than with 
the other two modes, with the difference just reaching the level of 
significance (23% for PSV, 43% for T piece, 42% for SIMV; p = 0.05). 
After excluding patients whose weaning was terminated for complications 
unrelated to the weaning process, the difference became highly significant 
(8% for PSV versus 33% and 39%, p < 0.025) 8 
 
          Esteban et al 26. also compared the extubation outcome after 
spontaneous breathing trials with T- tube or pressure support ventilation. 
Patients were randomly assigned to undergo a 2-h trial of  spontaneous 
breathing in one of two ways: with a T-tube system or with pressure support 
ventilation of 7 cm H2O. If a patient had signs of poor tolerance at any time 
during the trial, mechanical ventilation was reinstituted. Patients without 
these features at the end of the trial were extubated. Of the 246 patients 
assigned to the T-tube group, 192 successfully completed the trial and were 
extubated; 36 of them required reintubation. Of the 238 patients in the group 
receiving pressure support ventilation, 205 were extubated and 38 of them 
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required reintubation. The percentage of patients who remained extubated 
after 48 h was not different between the two groups (63% T-tube, 70% 
pressure support ventilation, p= 0.14). The percentage of patients failing the 
trial was significantly higher when the T-tube was used (22 versus 14%, p = 
0.03). Clinical evolution during the trial was not different in patients 
reintubated and successfully extubated. ICU mortality among reintubated 
patients was significantly higher than in successfully extubated patients (27 
versus 2.6%, p  0.001). Spontaneous breathing trials with pressure support or 
T-tube are suitable methods for successful discontinuation of ventilator 
support in patients without problems to resume spontaneous breathing. 
 
          Jones et al43. compared the effects of extubation after 1 h of either 
CPAP 5 & T – piece . 106 patients were randomized to 1 h CPAP or 1 h T – 
piece . no significant difference existed between groups in age , sex , HR , 
BP , FIO2 , PaCO2 , or PaO2. However P(A – a )O2 was significantly 
higher in CPAP group at the end of 120 min. 19 T – piece patients showed 
improved P(A – a) O2 at 120 min compared with only 10 patients in CPAP 
group. 3 CPAP and 2 T – piece patients subsequently required reintubation. 
This study demonstrates that use of a T – piece does not impair arterial 
oxygenation and may in fact be superior to extubation from CPAP  
 26
STUDY  JUSTIFICATION 
            Once a patient recovers from the illness leading to the application of 
mechanical ventilation, discontinuation of ventilator support and extubation 
must be attempted. Failure of extubation is associated with high mortality 
rate, either by selecting for high-risk patients or by inducing deleterious 
effects such as aspiration, atelectasis and pneumonia. 
             There are various standard protocols to classify which child is to be 
weaned and which not. But once the decision to wean from mechanical 
ventilator is made there is no universally accepted protocol as to which 
method of weaning is best. There is uncertainty about the best methods for 
conducting this process. 
          Current practice in our PICU as far as weaning is concerned is 
physician directed weaning. Physician directed weaning is an accepted mode 
of weaning where the intensive care specialist who by his experience decides 
as which patient is ready for weaning and which method of weaning is to be 
followed. Since all the methods of weaning are standard methods, patients 
are randomly weaned using any one method as wished by the physician. 
There is either undue delay to wean a right patient or an unnecessary early 
extubation in some patients which increase the duration of ventilation and 
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need for reintubation respectively in them, both of which are associated with 
increased rate of mortality & morbidity.To avoid such complications there 
need to be a single standard effective method which could be applied at any 
time the patient becomes fit for weaning. 
                  All 3 methods of weaning are accepted universally. But recent 
researches (most of them conducted in adults) actually show that one method 
is better over the other. Some studies show t- piece trial24 to be better some 
saying CPAP/PS is better, as far as weaning success25 is considered. Even if 
all methods are equally effective the actual duration of weaning differ from 
one method to another. For this purpose a comparative study of the various 
methods of weaning from mechanical ventilators was undertaken at PICU, 
ICH & HC where > 500 patients are intubated and ventilated per year to find 
out a quick and effective method of weaning  so that more patients would be 
benefited from the minimal number of ventilators available. The study  was 
approved by the hospital ethical committee. 
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AIM OF THE STUDY 
 
 
 
 
 
          To assess the effectiveness of the 3 standard methods of weaning from 
mechanical ventilators namely T – tube weaning, synchronized intermittent 
mandatory ventilation (SIMV) , continuous positive airway pressure / 
pressure support ( CPAP/PSV) ventilation in terms of successful weaning, to 
assess the incidence of weaning failure and duration of weaning with each 
and also the duration of hospital stay and outcome of these patients so that 
the best of the weaning procedure can be followed for successful weaning in 
future. 
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MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
 
Study Design 
 
                     Randomized  trial. 
 
Study Place 
             
              Pediatric intensive care unit 
                   
                  Institute of child health & hospital for children 
 
Period of study    
                 
              From June 2009 to November 2010. 
 
Study population 
  
              Children between 1 month and 12 years of age. 
 
Inclusion criteria 
 
1. All children who were mechanically ventilated for a period of > 
48 hours (irrespective of etiology) through an endotracheal tube 
and who  fulfill standard weaning criteria. 
2. Those who are reintubated after 48 hours of extubation and 
continue to receive mechanical ventilation for > 48 hours & 
fulfill weaning criteria. 
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Exclusion criteria 
                                  
                                 - ventilation for less than 48 hours  
                                                  
                                           - Ventilation with tracheostomy tube 
                                                  
                                           - Spontaneously extubated. 
                                                   
  - post operative patients. 
 
 Manoeuvre 
 
          First step in the process was to get informed consent for inclusion in 
the study from the patient’s care givers. After getting informed consent, 
children who satisfy the criteria for weaning ( as per ANNEXURE 1 ) are 
allocated computer generated random numbers and were categorized into 
group A/B/C accordingly. 
WEANING SUCCESS 12 : Defined as effective spontaneous breathing 
without any mechanical assistance for 48 hours or more 
WEANING FAILURE 12: Defined as one of the following:  
1) reintubation and/or resumption of ventilatory support following successful 
extubation with in 48 hrs or 
 2) death within 48 h following extubation. 
TRIAL FAILURE : During a breathing trial if the child developed signs of 
intolerance. 
TRIAL SUCCESS : Successful completion of a 2 hours of breathing trial.   
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AFTER FULLFILLING WEANING CRITERIA, CHILDREN ARE 
RANDOMISED 
                                                                   ↓ 
 
 
 
 
 
Success         failure          Success              failure                          Success            failure 
 
 
Extubation     back to                                                    reduce 2 breaths                 failure in   
                       Prior settings                                            for each                             any step   
                       Trial after                                      successful trial(2 trial/day)           go back  
                       24 hours                                                                                              to prior 
                                                                                       Till rate is                           settings. 
                                                                                       ≤ 50% of initial rate         trial after                         
                                                                                                                                24 hours. 
                                                                                       Extubate 
        Reduce PS by 2 cms/ H2O for        back to prior 
each Successful trial (2 trial/day)             settings. Trial                                   . 
               Till 6 cms/ H2O                        after 24 hours 
                                                                
                           
                 Extubation 
 
 
 
 
 
WEANING 24-26 
GROUP A 
T- PIECE TRIAL 
2 hours of breathing 
trial  
GROUP B 
CPAP/PSV 
2 hours of breathing 
trial with PEEP=5 
PSV=10cms/ H2O
GROUP C 
SIMV- V/P 
2 hours of breathing 
trial with RR of 50% 
of previous rate.
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T – piece trial : 
          After fulfilling weaning criteria the child is connected to a T – piece 
and a breathing trial for 2 hrs is conducted. If no signs of intolerance child is 
extubated. 
CPAP/PSV : 
          After fulfilling weaning criteria the child is connected to CPAP/PSV 
mode with PEEP of 5 & Pressure support of 10. After completion of a 2 hrs 
of breathing trial PS is reduced by 2 till it comes to 6, then extubation is 
done. Only 2 successful trials per day one after the other. If there is trial 
failure next trial is done after 24 hrs. 
SIMV : 
          After fulfilling weaning criteria the child is connected to SIMV mode 
with a rate that is 50% of the previous rate. After completion of a 2 hrs of 
breathing trial rate is reduced by 2 till it comes to 50% of the rate at which 
the trial was started, then extubation is done. Only 2 successful trials per day 
one after the other. If there is trial failure next trial is done after 24 hrs. 
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AT ANY POINT DURING TRIAL OF BREATHING IF CHILD FULFILS ANY 
OF THE CRITERIA (ANNEXURE 2) FOR  STOPPING SBT (spontaneous 
breathing trial) TRIAL IS TERIMINATED ABRUPTLY. 
 
END POINT FOR SIMV TRIAL: till ventilator rate of  ≤ 50% of initial rate.  
END POINT FOR CPAP/PSV TRIAL: till pressure support of 6 cms/ H2O. 
 
Sample size 
Calculated sample size is 30 in each group with a total of 90. 9 additional 
samples for loss during study period. Total sample size is 99 of which 96 
was achieved and 88 completed the study. 
 
Statistical analysis 
Chi – square test was used to compare categorical responses between 
children weaned using T – piece, CPAP – PSV and SIMV methods. One 
way ANOVA test and Post hoc test were used to compare the mean 
difference between the three groups. 
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PROFORMA 
NAME 
                                         
 
AGE/SEX 
                                         
 
IP.NO  
 
 
RANDOM NUMBER 
 
 
GROUP 
 
 
DIAGNOSIS  
 
 
 
COMORBIDITY  
 
 
 
 
        Hb% 
 
 
DATE/TIME OF 
INTUBATION 
 
 
 
INDICATION FOR 
INTUBATION 
 
 
 
 
 
TUBE SIZE 
 
 
REINTUBATIONS 
 
YES 
 
 
Number Indication  
1. 
2. 
3. 
 
 
 
NO 
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RAPID SEQUENCE 
INTUBATION 
YES 
 
 
 NUMBER  
NO  
 
SHOCK YES 
 
 
 DURATION  
NO 
 
 
INOTROPES YES 
 
 
 DURATION  
NO 
 
 
MANUAL 
VENTILATION 
YES 
 
 
 
STARTED ON:                    @ 
 
ENDED ON:                        @ 
 
NO 
 
 
MODE OF 
MECHANICAL 
VENTILATION 
PRIOR TO WEANING 
ASSISTED VOLUME 
CONTROL 
ASSISTED PRESSURE 
CONTROL 
FiO2 Tidal 
volume
Rate/ 
min 
FiO2 PIP PEEP Rate/ 
min 
 
 
 
      
DURATION OF 
MECHANICAL 
VENTILATION 
PRIOR TO WEANING 
 
STARTED ON:                        @                          
 
ENDED ON:                             @ 
 
NOSOCOMIAL 
PNEUMONIA 
    YES 
 
 
 
     NO 
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WEANING 
PROCEDURE 
 
 
 
NO OF SBT 
 
 
DURATION OF 
WEANING 
 
WEANING FAILURE 
( < 48 hours ) 
 
YES REINTUBATION 
 
 
DEATH  
NO  
INDICATION FOR 
REINTUBATION 
 
Airway cause: 
 
Non airway cause: 
 
 
DURATION OF PICU 
STAY 
 
DURATION OF 
HOSPITAL STAY 
 
OUTCOME 1.death 
2.complete recovery from underlying acute illness 
with out complications 
3. complete recovery from underlying acute illness 
following complications 
Complication- 
 
 
 
4.sequele: 
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RESULTS 
 
          Out of the 96 children included in the study 88 children successfully 
completed the study. 8 children were excluded from the weaning trial due to 
spontaneous extubation during the course of the trial. All 31 children from 
group A completed the trial successfully. 31 out of 33 children from group B 
completed the trial. 26 out of 32 children from group C successfully 
completed the trial. 
 
TABLE 1 
 
AGE DISTRIBUTION OF CHILDREN IN EACH GROUP 
 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
  
< 1 yr 20 64.5
1 – 4 yrs 10 32.3
4 – 8 yrs   
 8 – 12 yrs 1 3.2
Total 31 100.0
Group-B 
  
  
  
  
< 1 yr 20 64.5
1 – 4 yrs 7 22.6
4 – 8 yrs 3 9.7
 8 – 12 yrs 1 3.2
Total 31 100.0
Group-C 
  
  
  
  
< 1 yr 11 42.4
1 – 4 yrs 8 30.8
4 – 8 yrs 6 23
 8 – 12 yrs 1 3.8
Total 26 100.0
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          SEX DISTRIBUTION OF CHILDREN IN EACH GROUP 
 
     61.3 % of children in group A , 45.1 % in group B and 61.5 % in group C 
were boys and the rest were girls in each group. Both sexes were equally 
distributed. 
TABLE 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19
16
19
12
17
13
0
5
10
15
20
25
30
N
um
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r
Male Female
Gender
Gender distribution
Group-A
Group-B
Group-C
 
Treatment Group Frequency Percent 
 
 
P 
value 
Group-A 
  
  
Male 19 61.3  
 
 
 
 
0.342 
Female 12 38.7
Total 31 100.0
Group-B 
  
  
Male 14 45.1
Female 17 54.9
Total 31 100.0
Group-C 
  
  
Male 16 61.5
Female 10 38.5
Total 26 100.0
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RSI 
 
          16.1 % of children in group A , 6.1 % of children in group B and 15.6 
% of children in group C were intubated using Rapid Sequence Intubation. 
 
COMPARISONS OF VARIOUS DIAGNOSIS AMONG GROUPS 
 
 
16
12
13
1
0
1
9
15
14
3 3
1 2
3 3
0
5
10
15
20
25
30
N
um
be
r
Respiratory Cardiac Neurological Sepsis Others
Diagnosis
Distribution of diagnosis
Group-A
Group-B
Group-C
 
Respiratory  P -  Value: 0.304   
Cardiac   P – Value: 0.566   
Neurological  P – Value: 0.283   
Sepsis            P – Value: 0.913   
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TABLE 3 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
  
  
Respiratory 16 51.6 
Cardiac 1 3.2 
Neurological 9 29.0 
Sepsis 3 9.7 
Others 2 6.5 
Total 31 100.0 
Group-B 
  
  
  
  
  
Respiratory 10 32.2 
Cardiac    
Neurological 15 48.4 
Sepsis 3 9.7 
Others 3 9.7 
Total 31 100.0 
Group-C 
  
  
  
  
  
Respiratory 11 42.3 
Cardiac 1 3.8 
Neurological 11 42.3 
Sepsis 1 3.8 
Others 2 7.8 
Total 26 100.0 
 
   
          Neurological illnesses were the major cause of hospitalization among 
children of 2 groups. 48.4 % in group B , 42.3 % in group C had 
neurological diseases. But in group A 51.6 % had respiratory diseases. The 
distribution of diseases was equal among all the 3 groups. 
          71 % of children in group A , 72.7 % in group B and 62.5 % in group 
C had no associated co-morbidities. 
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INDICATION FOR INTUBATION 
 
TABLE 4 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
  
Pulmonary edema 13 41.9
Status epilepticus 3 9.7
Respiratory failure 12 38.7
Poor GCS 3 9.7
Total 31 100.0
Group-B 
  
  
  
  
Pulmonary edema 9 29
Status epilepticus 10 32.3
Respiratory failure 10 32.3
Poor GCS 2 6.4
Total 31 100.0
Group-C 
  
  
  
  
Pulmonary edema 8 30.8
Status epilepticus 7 27
Respiratory failure 8 30.8
Poor GCS 3 11.4
Total 26 100.0
 
          
 
           Pulmonary edema and respiratory failure were the major indications 
for intubation among children of all groups. In group A 41.9 % and 38.7 % , 
in group B 29 % and 32.3 % , in group C 30.8 % had pulmonary edema and 
respiratory failure respectively. 9.7 % , 32.3 % and 27 % in groups A,B and 
C were intubated for status epilepticus. Poor GCS was the other indication 
for intubation in these children.  
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Pulmonary edema Status epilepticus Respiratory failure
Indication
Indication for intubation
Group-A
Group-B
Group-C
  
 
 
Pulmonary edema  P – Value:0.514  
Status epilepticus  P – Value:0.088  
Respiratory failure  P – Value:0.791  
Poor GCS     P – Value:0.793  
 
             
          There was no statistically significant difference in the distribution of  the  
 
various indications for intubation among groups. 
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TABLE 5 - SHOCK 
 
Treatment Group Frequency Percent 
 
P 
value 
Group-A 
  
  
No 9 29.0  
 
 
 
 
0.669 
Yes 22 71.0
Total 31 100.0
Group-B 
  
  
No 12 38.7
Yes 19 61.3
Total 31 100.0
Group-C 
  
  
No 10 38.5
Yes 16 61.5
Total 26 100.0
 
TABLE 6 - DURATION OF SHOCK 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
< 24hrs 13 59.1 
24 - 48hrs 6 27.3 
> 48hrs 3 13.6 
Total 22 100.0 
Group-B 
  
  
  
< 24hrs 9 47.4 
24 - 48hrs 7 36.8 
> 48hrs 3 15.8 
Total 19 100.0 
Group-C 
  
  
  
< 24hrs 8 50 
24 - 48hrs 6 37.5 
> 48hrs 2 12.5 
Total 16 100.0 
 
          71 % in group A , 61.3 % in group B and 61.5 % in group C had 
shock during sometimes of their illness. In majority of them shock persisted 
for < 24 hrs. only 13.6 % , 15.8 % & 12.5 % in group A , B & C had shock 
for > 48 hrs.  
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INOTROPES – TABLE 7 
 
Treatment Group Frequency Percent 
Group-A 
  
  
No 12 38.7
Yes 19 61.3
Total 31 100.0
Group-B 
  
  
No 16 51.6
Yes 15                48.4
Total 31 100.0
Group-C 
  
  
No 12 46.1
Yes 14 53.9
Total 32 100.0
 
DURATION OF INOTROPES – TABLE 8 
 
Treatment Group Frequency Valid Percent
Group-A 
  
  
  
< 24hrs 10 52.6
24 - 48hrs 6 31.6
> 48hrs 3 15.8
Total 19 100.0
Group-B 
  
  
  
< 24hrs 5 33.3
24 - 48hrs 7 46.7
> 48hrs 3 20
Total 15 100.0
Group-C 
  
  
  
< 24hrs 6 42.8
24 - 48hrs 6 42.8
> 48hrs 2 14.4
Total 14 100.0
 
          More than 50 % of children received inotropic support for shock 
management. Only in  group B (46.7 %) inotropes were used for 24 – 48 hrs  
where as in groups group A (52.6 %) and group C (42.8 %) inotropes were 
used only for < 24 hrs.  
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VENTILATION BEFORE WEANING 
 
          26 out of 31 children (84 %) in group A , 29 out of 31 children (93.5 
%) in group B and 24 of 26 children (92.3 %) in group C received manual 
ventilation prior to mechanical ventilation which was equally distributed 
among groups. 
          29 out of 31 (93.5 %) in group A , 28 out of  31 (90.3 %) in group B 
and 21out of 26 (80.8 %) in group C received pressure control ventilation 
before weaning. 
8
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Duration of ventilation before weaning
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TABLE 9 
 
DURATION OF VENTILATION PRIOR TO WEANING 
 
Treatment Group Frequency Percent 
 
P value 
Group-A 
  
  
  
 48 to <72 hrs 8 25.8  
 
 
 
 
  0.226 
3 to <5 days 11 35.5 
5 to < 10 days 6 19.4 
  
>= 10 days 6 19.4 
Total 31 100.0 
 Group-B 
  
  
  
  
 48 to <72 hrs 2 6.5 
3 to <5 days 15 48.4 
5 to < 10 days 11 35.5 
>= 10 days 3 9.6 
Total 31 100.0 
 Group-C 
  
  
  
  
 48 to <72 hrs 6 23.1 
3 to <5 days 10 38.5 
5 to < 10 days 5 19.2 
>= 10 days 5 19.2 
Total 26 100.0 
 
           
 
          The duration of  ventilation prior to weaning was equally distributed  
 
among groups. There is no significant difference since the P value is 0.226 
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WEANING CRITERIA 
 
TABLE 10 - NUMBER OF CRITERIA FULFILLED 
 
Treatment Group Frequency Percent 
Group-A 
7   
8 18 58.1
9 13 41.9
Total 31 100.0
Group-B 
7 1 3.2
8 12 38.7
9 18 58.1
Total 31 100.0
Group-C 
7 2 7.7
8 9 34.6
9 15 57.7
Total 26 100.0
 
 
All 9 criteria were fulfilled by 41.9 % , 61.5 % & 57.7 % of children in 
groups A , B & C respectively. 
8 criteria were fulfilled by 58.1 % , 35.5 % & 34.6 % of children in groups A 
, B & C respectively. 
7 criteria were fulfilled by 3.2 % & 7.7 % of children in groups B & C 
respectively. 
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NOSOCOMIAL PNEUMONIA 
 
TABLE 11 
 
Treatment Group Frequency Percent 
 
 
P value
Group-A 
  
  
Yes 1 3.2   
 
 
 
  0.023 
No 30 96.8 
Total 31 100.0 
Group-B 
  
  
Yes 9 29 
No 22 71 
Total 31 100.0 
Group-C 
  
  
Yes 6 23 
No 20 77 
Total 26 100.0 
 
 
 
          The incidence of nosocomial pneumonia was significantly lower in  
 
group A ( 1 out of 31 = 3.2 % ) than in group B ( 9 out of 31 = 29 % ) and  
 
group C ( 6 out of 32 = 23 % ). This was statistically significant with a P  
 
value of  0.023. 
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WEANING TRIALS 
 
NUMBER OF TRIALS 
 
27
1 1
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N
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Number of trials
Number of trials
Group-A
Group-B
Group-C
 
          
 
           27 out of 31 children in group A (87.1 %) required only 1 trial for 
weaning. Whereas in group B 23 out of 31 (74.1 %) children required 3 
trials. In group C 12 out of 26 (46.1 %) children needed 4 trials and 8 out of 
26 (30.7 %) needed 3 trials thereby increasing the duration of weaning in 
groups B & C. 
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TABLE 12   
 
Oneway ANOVA test for number of trials 
 
 
  N Mean 
Std. 
Deviation
Std. 
Error
95% 
Confidence 
Interval  Range 
P 
value          
Lower 
Bound
Upper 
Bound
Minim
um  
Maxim
um  
Group-
A 31 1.13 .341 .061 1.00 1.25 1 2 0.000
Group-
B 31 3.27 .876 .152 2.96 3.58 3 6
Group-
C 26 3.66 1.208 .214 3.22 4.09 3 6
Total 88 2.71 1.414 .144 2.42 2.99 1 6
          
 
 
Number of trials needed for weaning was least in group A with a mean of 
1.13 where as in groups B & C it was 3.27 & 3.66 respectively. This was 
statistically significant with a P value of 0.000. 
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TABLE 13 
 
post Hoc test - Multiple Comparisons 
  
 
(I) Treatment 
Group 
(J) Treatment 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error P value 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Group-A 
Group-A      
Group-B -2.14(*) .222 .000 -2.68 -1.60
Group-C -2.53(*) .224 .000 -3.07 -1.98
Group-B 
Group-A 2.14(*) .222 .000 1.60 2.68
Group-B      
Group-C -.38 .220 .255 -.92 .15
Group-C 
Group-A 2.53(*) .224 .000 1.98 3.07
Group-B .38 .220 .255 -.15 .92
Group-C      
*  The mean difference is significant at the .05 level. 
 
           
          Even on multiple comparisons group A was found to have statistically 
significant less number of trials ( P value of 0.000 ) than group B & C. 
There was no statistically significant difference between groups B & C. 
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NUMBER OF TRIAL FAILURE 
 
TABLE 14 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
  
0 27 87.1
1 4 12.9
2   
3   
Total 31 100.0
Group-B 
  
  
  
  
0 23 74.2
1 6 19.3
2 1 3.2
3 1 3.2
Total 31 100.0
Group-C 
  
  
  
  
0 14 53.8
1 7 26.9
2 4 15.3
3 1 3.8
Total 26 100.0
 
            
          In group A only 4 out of 31 (12.9%) had 1 trial of SBT failed. In 
group B 6 out of 31 (19.3%) had 1 trial failure. 3.2% had 2 and 3trial failures 
respectively. In group C 7 out of 26 (26.9%) , 4 out of 26 (15.3%) and 1 out 
of 26 (3.8%) had 1, 2 and 3 trial failures respectively. 
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TABLE 15  
 
 Cross table & chi – square test 
 
 
 Treatment Group Total 
  Group-A Group-B Group-C   
No. of trial 
failure None 27 23 14 44
   Percent 87.1% 74.1% 53.8% 72.7%
  One or more 4 8 12 24
   Percent 12.9% 25.9% 46.2% 27.3%
Total 31 31 26 88
  100.0% 100.0% 100.0% 100.0%
P value 0.041  
 
          
          
            In group A number of trial failures were significantly less with P value  
 
of 0.041 compared with groups B & C. 
 
 
 
 
 
 
 
 
 56
DURATION OF WEANING 
 
TABLE 16 - One way ANOVA for duration of weaning 
 
 
N 
Mean 
(hrs) 
Std. 
Deviati
on 
Std. 
Error 
 
95% Confidence 
Interval 
 Range  
 
 
 
 
 
P 
valueLower 
limit 
Upper 
limit 
Mini
mum 
Maxi
mum 
Group
-A 31 5.10 8.179 1.469 2.10 8.10 2 26
 
Group
-B 31 31.87 14.796 2.657 26.44 37.30 26 98
 
Group
-C 26 39.28 19.250 3.850 31.33 47.23 26 98
 
Total 88 24.46 20.540 2.202 20.08 28.84 2 98 0.000 
 
Mean Duration of Weaning
39.28
31.87
5.1
0
10
20
30
40
50
60
Group-A Group-B Group-C
Group
M
ea
n 
du
ra
tio
n 
(h
ou
rs
)
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          The mean duration of  weaning in group A is 5.1 hrs, with minimum 
of 2 hrs and maximum of 26 hrs. In group B it is 31.87 hrs, with minimum 
of 26 hrs and maximum of 98 hrs. In group C mean duration of weaning is 
39.28 hrs, with minimum of 26 hrs and maximum of 98 hrs. 
          The duration of weaning is shortest in group A (5.1 hrs ± 2.9) 
which is statistically significant with P value of 0.000. 
TABLE 17 - Post Hoc Tests   -    Multiple Comparisons 
 
(I) Treatment 
Group 
(J) Treatment 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error P value 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Group-A 
Group-A      
Group-B -26.77(*) 3.663 .000 -35.72 -17.83
Group-C -34.18(*) 3.876 .000 -43.65 -24.71
Group-B 
Group-A 26.77(*) 3.663 .000 17.83 35.72
Group-B      
Group-C -7.41 3.876 .178 -16.88 2.06
Group-C 
Group-A 34.18(*) 3.876 .000 24.71 43.65
Group-B 7.41 3.876 .178 -2.06 16.88
Group-C      
*  The mean difference is significant at the .05 level. 
 
  Even on multiple comparisons with groups B and C, group A was found 
to have statistically significant shorter duration of weaning with a P 
value of 0.000. There was no statistically significant difference among 
groups B & C.  
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WEANING FAILURE 
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 In group A 1 out of 31 failed weaning (3.2%)  
 
 In group B 6 out of  31 failed weaning (19.4%)  
   
 In group C 8 out of 26 failed weaning (30.8%) 
 
         
          Weaning was successful in 96.8% of children in group A , 80.6% of  
children in group B & 69.2 % of  children in group C. 
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TABLE 18 
 
Weaning failure 
 
 Treatment Group Frequency 
Valid 
Percent P value 
Group-A 
  
  
No 30 96.8 
Yes 1 3.2 0.021
Total 31 100.0 
Group-B 
  
  
No 25 80.6 
Yes 6 19.4 
Total 31 100.0 
Group-C 
  
  
No 18 69.2 
Yes 8 30.8 
Total 26 100.0 
 
           
 
 
          Group A had statistically less weaning failure than the other 2  
 
groups  with a P value of 0.021. 
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OUTCOME MEASURES 
 
TABLE 19 
 
Treatment Group Frequency Percent 
Group-A 
  
  
  
Death 1 3.2
Recovery without 
complication 25 80.6
Recovery with complication 5 16.1
Total 31 100.0
 Group-B 
  
  
  
Death 5 16.1
Recovery without 
complication 20 64.6
Recovery with complication 6 19.3
Total 31 100.0
 Group-C 
  
  
  
Death 5 19.3
Recovery without 
complication 16 61.5
Recovery with complication 5 19.2
Total 26 100.0
 
 
          All children included in the study were followed up throughout their 
hospital stay and their outcomes were observed.  
In group A 80.6 % recovered without complications, 16.1 % recovered with 
complications & 3.2 % died.  
In group B 66.7 % recovered without complications, 18.2 % recovered with 
complications & 15.2 % died.  
In group A 62.5 % recovered without complications, 21.9 % recovered with 
complications & 15.6 % died.  
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The outcome measures were not statistically significant between the  
 
groups. P value is 0.430. 
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TABLE 20 - Factors associated with Weaning failure: Group-A 
 
Treatment Group 
Weaning failure 
Total Chi-
square 
value 
P-Value No Yes 
N % N % N % 
Number of 
criteria 
fulfilled 
  
  
8 17 94.44 1 5.56 18 100 
0.746 0.388 9 13 100   13 100 
7        
Sex  
  
Male 18 94.74 1 5.26 19 100 
0.653 0.419 
Female 12 100   12 100 
Diagnosis 
  
  
  
  
Respiratory 16 100   16 100 
2.526 0.640 
Cardiac 1 100   1 100 
Neurological 8 88.89 1 11.11 9 100 
Sepsis 3 100   3 100 
Others 2 100   2 100 
Comorbidity 
  
No 21 95.45 1 4.55 22 100 
0.423 0.516 
Yes 9 100   9 100 
Shock 
  
No 8 88.89 1 11.11 9 100 
2.526 0.112 
Yes 22 100   22 100 
Inotropes 
  
No 11 91.67 1 8.33 12 100 
1.636 0.201 
Yes 19 100   19 100 
Nosocomial 
pneumonia  
Yes 1 100   1 100 
0.034 0.853 
No 29 96.67 1 3.33 30 100 
Number of 
trial 
  
1 26 96.30 1 3.70 27 100 
0.153 0.696 
2 4 100   4 100 
Number of 
trial failure 
  
0 26 96.30 1 3.70 27 100 
0.153 0.696 
1 4 100   4 100 
Total 30 96.77 1 3.23 31 100   
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TABLE 21 - Factors associated with Weaning failure: Group-B 
 
Treatment Group 
Weaning failure 
Total Chi-
square 
value 
P-Value No Yes 
N % N % N % 
Number of 
criteria 
fulfilled 
  
  
8 7 63.64 4 36.36 11 100 
3.228 0.199 9 17 89.47 2 10.53 19 100 
7 1 100   1 100 
Sex  
  
Male 13 92.86 1 7.14 14 100 
2.439 0.118 
Female 12 70.59 5 29.41 17 100 
Diagnosis 
  
  
  
  
Respiratory 7 70.00 3 30.00 10 100 
2.170 0.538 
Cardiac        
Neurological 13 86.67 2 13.33 15 100 
Sepsis 3 100   3 100 
Others 2 66.67 1 33.33 3 100 
Comorbidity 
  
No 19 86.36 3 13.64 22 100 
1.588 0.208 
Yes 6 66.67 3 33.33 9 100 
Shock 
  
No 9 75.00 3 25.00 12 100 
0.400 0.527 
Yes 16 84.21 3 15.79 19 100 
Inotropes 
  
No 13 81.25 3 18.75 16 100 
0.008 0.930 
Yes 12 80.00 3 20.00 15 100 
Nosocomial 
pneumonia  
Yes 8 88.89 1 11.11 9 100 
0.552 0.457 
No 17 77.27 5 22.73 22 100 
Number of 
trial 
  
  
  
3 21 91.30 2 8.70 23 100 
11.613 0.009 
4 3 60.00 2 40.00 5 100 
5   2 100 2 100 
6 1 100   1 100 
Number of 
trial failure 
  
  
  
0 21 91.30 2 8.70 23 100 
9.691 0.021 
1 3 50.00 3 50.00 6 100 
2   1 100 1 100 
3 1 100   1 100 
Total 25 80.65 6 19.35 31 100   
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TABLE 22 - Factors associated with Weaning failure: Group-C 
 
Treatment Group 
Weaning failure 
Total Chi-
square 
value 
P-ValueNo Yes 
N % N % N % 
Number of 
criteria 
fulfilled 
  
  
8 7 77.78 2 22.22 9 100 
4.927 0.085 9 11 73.33 4 26.67 15 100 
7   2 100 2 100 
Sex  
Male 13 81.25 3 18.75 16 100 
2.821 0.093 
Female 5 50.00 5 50.00 10 100 
Diagnosis 
  
  
  
  
Respiratory 6 54.55 5 45.45 11 100 
3.168 0.530 
Cardiac 1 100   1 100 
Neurological 9 81.82 2 18.18 11 100 
Sepsis 1 100   1 100 
Others 1 50.00 1 50.00 2 100 
Comorbidity 
  
No 11 73.33 4 26.67 15 100 
0.280 0.597 
Yes 7 63.64 4 36.36 11 100 
Shock 
  
No 8 80.00 2 20.00 10 100 
0.885 0.347 
Yes 10 62.50 6 37.50 16 100 
Inotropes 
  
No 9 75.00 3 25.00 12 100 
0.348 0.555 
Yes 9 64.29 5 35.71 14 100 
Nosocomial 
pneumonia  
Yes 4 66.67 2 33.33 6 100 
0.024 0.877 
No 14 70.00 6 30.00 20 100 
 Number of 
trial 
  
  
  
3 5 62.50 3 37.50 8 100 
3.115 0.374 
4 10 83.33 2 16.67 12 100 
5 2 66.67 1 33.33 3 100 
6 1 33.33 2 66.67 3 100 
Number of 
trial failure 
  
  
  
0 14 100   14 100 
14.432 0.002 
1 3 42.86 4 57.14 7 100 
2 1 25.00 3 75.00 4 100 
3   1 100 1 100 
Total 18 69.23 8 30.77 26 100   
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FACTORS ASSOCIATED WITH WEANING FAILURE 
 
 
GROUP B: In group B, children who required more trials ( P 0.009 ) for 
weaning & those who had more trial failures ( P 0.021 ) had statistically 
significant weaning failure. 
GROUP C: In group C, children who had more trial failures ( P 0.002 ) had 
statistically significant weaning failure. 
 
FINAL COMPARISON OF MAJOR OUTCOME VARIABLES 
 
TABLE 23 
 
  
GROUP A 
 
 
GROUP B 
 
 
GROUP C 
 
P – VALUE 
 
WEANING 
FAILURE 
N 
YES 
NO 
 
 
 
 
31 
1 
30 
 
 
 
31 
6 
25 
 
 
 
26 
8 
18 
 
 
 
 
0.021 
 
NUMBER OF 
TRIALS 
(MEAN) 
 
          1.13 ± 
0.061 
 
       3.27 ± 
       0.152 
 
 
         3.66 ± 
0.214 
 
 
 
 
0.000 
 
DURATION 
OF WEANING 
(MEAN) 
 
         
   5.1 +/-   1.469 
 
 
31.87 +/- 2.657 
 
 
39.28 +/- 3.850 
 
 
       0.000 
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DISCUSSION 
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DISCUSSION 
 
          In this randomized control trial of comparing the three methods of 
weaning  ( T – piece trial , CPAP / PSV & SIMV ) from mechanical 
ventilators in children aged 1 month to 12 years , the results were analysed 
using appropriate statistical tests. In our study weaning was successful as 
well as duration of weaning was shorter in T – Piece technique than the 
other two. 
Intermittent Mandatory Ventilation 
          Several advantages have been claimed for intermittent mandatory 
ventilation as a weaning technique: it is supposed to prevent a patient from 
“fighting” the ventilator, reduce respiratory-muscle fatigue, and expedite 
weaning. However, there are few data to support these claims24,26Intermittent 
mandatory ventilation is usually delivered in a synchronized manner with 
demand- valve circuitry, which increases the work of breathing. The 
intermittent nature of assistance also poses a problem. It was previously 
assumed that the degree of respiratory-muscle rest was proportional to the 
level of machine assistance. However, recent evidence indicates that 
respiratory-sensor output does not adjust to breath-to-breath changes in 
respiratory load, and intermittent mandatory ventilation may therefore 
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contribute to the development of respiratory muscle fatigue or prevent 
recovery from it. 
        Studies of the efficacy of intermittent mandatory ventilation in weaning 
have serious limitations. Schachtern et al44. compared it with conventional 
ventilation & noted no difference between the two techniques in the duration 
of ventilator support. Their study suffers from a retrospective design 
nonuniform study groups, and inadequate description of the protocol. 
Esteban etal24  compared it with single daily and multiple daily spontaneous 
breathing trials with t- piece and pressure ventilation and found SIMV as the 
poorest method of weaning. On comparison with single daily T – piece trial 
P value was < 0.006. In our study P value was 0.000. 
Pressure-Support Ventilation 
          Pressure-support ventilation is commonly used to counteract the work 
of breathing imposed by endotracheal tubes and ventilator circuits. 
Theoretically, this should help with weaning, because a patient who is 
comfortable at the compensatory level of pressure support should be able to 
sustain ventilation after extubation. However, the level of pressure support 
necessary to eliminate the work imposed by endotracheal tubes and 
ventilator circuits varies considerably (from 3 to 14 cm of water); thus, any 
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prediction of a patient’s ability to sustain ventilation after extubation is 
likely to be misleading24-26.  
          Brochard et al 25. recently reported that the duration of weaning was  
significantly shorter with pressure support (5.7 - 3.7 days) than with 
intermittent mandatory ventilation (9.9 - 8.2 days) or trials of spontaneous 
breathing (8.5 - 8.3 days). This is in contrast to the findings in our study 
where the duration of weaning was shortest with T – piece trial (mean 5.1 
hrs) as compared with CPAP / PSV (mean 31.87 hrs) and SIMV (39.28 hrs) 
with a P value of 0.000. Results of study conducted by Esteban etal where  
the median duration of weaning was 5 days for intermittent mandatory 
ventilation (first quartile, 3 days; third quartile, 11 days), 4 days for 
pressure-support ventilation (2 and 12 days, respectively), 3 days for 
intermittent (multiple) trials of spontaneous breathing (2 and 6 days, 
respectively), and 3 days for a once-daily trial of spontaneous breathing (1 
and 6 days, respectively) were similar to that in our study.  
T piece trial of spontaneous breathing 
          A once-daily trial of spontaneous breathing also allowed speedier 
weaning than approaches offering partial ventilatory support. This approach 
simplifies management, since a patient’s ability to breathe spontaneously 
without ventilatory support needs to be assessed only once a day. In contrast, 
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with intermittent mandatory ventilation and pressure-support ventilation, 
ventilator settings must be adjusted repeatedly and each adjustment is 
usually followed by an arterial-blood gas measurement 30,31.  
          An implied goal of the various weaning techniques is to recondition 
respiratory muscles that may have been weakened during the period of 
mechanical ventilation. Theoretically, a once-daily trial of spontaneous 
breathing and a prolonged period of rest may be the most effective method 
of eliciting adaptive changes. This approach meets the three principal 
requirements of a conditioning program: overload, specificity, and 
reversibility. During the trial, patients breathe against an elevated intrinsic 
load, thus satisfying the overload requirement35. Specificity is also satisfied, 
in that the trial is an endurance stimulus and the desired objective is 
enhanced endurance. Finally, the use of a daily trial prevents regression of 
the adaptive changes. It must be emphasized that this reasoning is based on 
indirect evidence and that the effect of different weaning techniques on 
respiratory-muscle reconditioning has not been investigated 35.  
          In our study T – piece trial was found to be superior in successful 
weaning    (30 out of 31 P value 0.021) as well as shorter duration of 
weaning ( mean of 5.1 hrs P value of  0.000) . This is similar to findings of 
Esteban et al where weaning was successful with T piece trial as compared 
 71
with pressure support ( p < 0.04 ) and intermittent mandatory ventilation ( P 
< 0.006 ). 
 
Comparison of this study with others 
 Esteban etal Brochard 
etal 
Esteban 
etal 
Jones 
etal 
Our study 
Compared  IMV 
PSV 
Single daily T 
piece 
Multiple daily T 
piece  
SIMV 
PSV 
T piece 
PSV 
T piece 
CPAP 
T 
piece 
SIMV 
CPAP/PSV 
T piece 
No. of 
patients 
130 109 484 106 88 
Weaning 
success 
Once daily T 
piece 
PSV equal equal T piece 
Duration 
of weaning 
IMV – 5 days 
PSV - 4 days 
Single daily T 
piece  & 
Multiple daily T 
piece – 3 days 
 
 
 
Shorter 
with PSV 
 
 
 
- 
 
 
 
- 
SIMV  
– 39.2 hrs 
CPAP/PSV 
– 31.8 hrs 
T piece  
– 5.1 hrs 
P value <0.006 <0.025 0.14 - 0.000 
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SUMMARY AND CONCLUSION 
 
          A randomized trial of comparing three methods of weaning from 
mechanical ventilators was completed in 88 children. 
From this study we conclude that, 
• Spontaneous extubation during weaning was least with T – piece trial. 
• Duration of weaning & number of trials needed for weaning was least 
with       T -  piece trial.  
• Weaning was ~ 6 times faster with T – piece than with CPAP/PSV 
and ~ 8 times faster than with SIMV. 
• Weaning success was also highest with T – piece trial. 
• Duration of weaning was not significantly different between 
CPAP/PSV & SIMV group  
• T – piece trial as a technique for weaning of children from mechanical 
ventilators is the best as far as duration and success of weaning is 
concerned. This is independent of age or sex or etiology or duration of 
ventilation prior to weaning or presence of shock or use of inotropes 
or the underlying disease process. 
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ANNEXURE 1 
                                                                                                            DATE 
NAME:                                                AGE/SEX:                             IP.NO 
 
S.NO WEANING CRITERIA ( 7 0ut of 9 )     YES      NO 
Etiology improving   
Alert mental status / GCS > = 11   
Good cough / gag reflex   
Temperature < 38.5 degree Celsius   
No clinical need for increase in ventilatory 
support in past 24 hours 
  
Hemodynamic stability 
- CRT< 3 sec 
- HR normal range for age* 
- Systolic BP normal range for age* 
- No further need for vasoactive agents
  
Parameters of oxygenation 
- SPO2 of > 94% on FiO2 of <= 0.5 
- PIP < 20cms/ h20 
- PEEP <= 5 
  
No acidosis  
- pH of 7.32 – 7.47 
- pCO2 < 50mm/Hg
  
Respiratory rate in acceptable range 
< 6 months      20 – 60 / min 
6m to 2 yrs      15 – 45 / min 
2 to 5 yrs         15 – 40 / min 
> 5 yrs             10 – 35 / min 
  
 
  
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
* 
AGE HEART RATE(HR) 
rates/min 
SYSTOLIC BP  
mm/Hg 
< 6 months 90 – 180 50 – 70 
6 months 85 – 170 65 – 106 
1 year 80 – 140 72 – 110 
3 year 80 – 130 78 – 114 
6 year 70 – 120 80 – 116 
8 year 70 – 110 84 – 122 
10 year 65 – 110 90 – 130 
12 year 60 – 110 94 – 136 
 
IF CRITERIA FULFILLED:              RANDOM NUMBER -                    GROUP –  
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ANNEXURE  2 
                                                                                                            DATE 
NAME:                                                AGE/SEX:                             IP.NO  
 
RANDOM NUMBER -                    GROUP – 
TRIAL NO STARTING TIME ENDING TIME 
 
 
  
 
GROUP TRIAL SETTINGS 
A  
T- piece 
 
B CPAP/PSV 
 
PEEP PS 
C 
 
SIMV RATE/MIN 
CRITERIA TO STOP SPONTANEOUS BREATHING TRIAL 
CRITERIA( yes to any 1 criteria ) yes no 
Inability to maintain gas exchange  
      - SPO2 < 95% with FiO2 of 0.4 
  
Inability to maintain effective ventilation 
- PCO2 of  > 50 mm/Hg or increase of > 10mm/Hg 
from previous value 
- pH < 7.3  
  
Increased work of breathing 
      -    Respiratory rate in acceptable range 
< 6 months      20 – 60 / min 
6m to 2 yrs      15 – 45 / min 
2 to 5 yrs         15 – 40 / min 
> 5 yrs             10 – 35 / min 
      -   increased use of accessory muscles of                        
respiration 
      -   paradoxical breathing                                                   
 
  
Signs of distress 
- diaphoresis 
- anxiety 
- change in mental status(agitation/somnolence) 
- BP – hyper/ hypo tension 
- Heart rate – Brady/ tachy cardia 
  
 
TRIAL OUTCOME – SUCCESS / FAILURE 
 
EXTUBATION TIME – 
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